NEW YORK ( TheStreet) -- In case you missed them, here are the top 10 most popular articles and videos on TheStreet today. Sign up for free email delivery of our daily Top 10.

The Five Dumbest Things on Wall Street This Week: April 27
Gregg Greenberg
Chesapeake's New Suit; Wal-Mart's Mexican Mess; Big Lots Goes Bust; BP's Bad Guy; Ratings Ridiculousness.

The Next Big Thing in Biotech: M&A
Adam Feuerstein
Senior columnist Adam Feuerstein says M&A is the next big thing in biotech.

Apple's Doomed? More Than One Person Thinks So
Rocco Pendola
The so-called Apple permabulls won't be able to see when the company goes from great to merely good.

Biotech Stock Mailbag: AVI, Aveo, Spectrum
Adam Feuerstein
Biotech columnist Adam Feuerstein answers readers' questions about health-care companies.

Coke Stock Split May Irk Warren Buffett
Don Dion
The chief of Berkshire Hathaway has criticized other companies in the past for stock splits and new share issuance.

4 Ex-Dividend Stocks With Buy Ratings: F, ASML, FAST, STX
Alexandra Zendrian
These stocks, which go ex-dividend Monday, are rated buy at TheStreet Ratings.

Wall Street Regains Some Strength
Andrea Tse
U.S. stocks tick back above the flat line Friday after digesting a cooler-than-expected GDP report and mixed earnings data.

Stocks to Watch: Amazon, Starbucks, Ford
Joseph Woelfel beats analysts' earnings estimates; Ford is expected to post results before Friday's opening bell.

Facebook Has No Business Being Compared to Apple, Google and Amazon
Richard Saintvilus
Sure, it runs a popular Web site, but the company hasn't proven that it's a sound business.

Analysts' Actions: AMZN, MDRX, EXPE, JBLU
TheStreet Staff
Here are today's top research calls.

This article was written by a staff member of TheStreet.